PERIOPERATIVE ANESTHESIA: TO DO OR NOT TO DO?
- Authors: Firsov S.A.1, Lepilov A.S.1, Matveev R.P.2, Savinkin V.S.3
-
Affiliations:
- Railway Clinical Hospital
- Northern State Medical University
- Hospital at Isakogorka Station
- Issue: Vol 25, No 2 (2018)
- Pages: 36-40
- Section: Articles
- URL: https://journals.eco-vector.com/0869-8678/article/view/47159
- DOI: https://doi.org/10.32414/0869-8678-2018-2-36-40
- ID: 47159
Cite item
Full Text
Abstract
Introduction. In patients with chronic loco-motor system diseases the pain often persists after arthroplasty and does not respond to symptomatic therapy.Purpose of study: to evaluate the efficacy of perioperative use of Meloxicam in patients after hip arthroplasty. Patients and methods. The follow-up covered 120 patients (mean age 64.4±5.23 years) after hip arthroplasty. In the main group (n=60) Meloxicam was given 7 days prior to and 3 weeks after surgery; after intervention narcotic analgesic was used on the request. In control group (n=60) the patients were only on narcotic analgesic on request after operation. Treatment results were assessed by 100-millimeter visual analog scale (VAS) and D’Aubigné-Postel Score.Results. Seven days before the surgery the pain severity in the main and control groups was comparable: 85±2.3 and 84±2.1, respectively. In 2 days after operation the pain relief was more pronounced in the main group — 69±2.1 mm versus 82±3.4 mm in the control group (p<0.05). In 3 months those indices made up 10±2.1 and 35±12.6 mm (p<0.001), respectively. In the main group the result was assessed as the excellent and good in 22 patients, in the rest of patients as satisfactory by d’Aubigné-Postel Score. In the control group the good result was recorded in 9, satisfactory — in 47 and poor — in 4 cases.Conclusion. Meloxicam may be considered as an effective perioperative analgesic in large joints arthroplasty.
Keywords
Full Text
¨©¡››¢¥¬®®Ÿ‘Ž\t‘Œœ®\t¨ªª®©¯°©«°°°¨©°ª±ƒ„„ ‚€‚ƒƒ‚²‘‰Ž‘‰Š™ŽŽŽ˜ž˜Ž–Š¹”–Š°–º‰„ƒ„Þ\f†‡ƒ„‰„Ž\r\f‡ª„…„Œ‡•„‰„‰\f\fŒƒˆ\f\f€‚\f“„„ºƒ“ê\n\t\b„…„‹\f\f\f\f\f\f \f\f‰êŒ„€‚\f†„„ºƒ‰\n‰\fׇ‹\r˜¦˜\r–\fž\f\f”\f“‹\f˜”\f\r™\f——\r\r‡™ž˜˜\f\r\r–\f\f´™\r“\f\f˜„…\f´”\r\f‹ž\f\fž\f”\r™™˜\f”\r”\f\r\f\f„\f“\f´©©\f\r\f\r–\f—\r\f”\f˜”\f”\r–\f‡\rŸ\fž´™\r“\f\f“‹™—„\r\f…™‹‚™\f”ž™\f\f¥¢¤\r–\fš™\f“·¡‡·Ø§‡¢£\rŸ\fž´™\r“\f\f“‹™—„•—\r\ršÐ·¤œ–‚‹“‹\f\f˜\f\r“\f”\f”‡“\f“¶™™\r–\f\f\f\f£™\r\r–\f\fÏ\r\r–\f\f«\f\f—\f\r‹\f‚„•—\r\ršÐ·¤œ\r–\f\r\f\f\f—\f\r‹\f‚\r\r–\f\f„ª“\f˜–\f\f\r¥¤¤”\f\f”\f“—Ÿ‹\fš•ƒÌœ\fŸ°Ê \t¾»\f¼„\n\t\fÔ¶™™\r–\f\f‹\f—\r\rž‹\r\f”Ò¨§Ø¢‡£””\f—\r\r„Õ“¢\r\r–\f\f—\r\r\f\f‹\f\f‹\f«·¬Ø¢‡¥””\r\f¨¢Ø£‡¡””—\r\ršµ¤‡¤§œ„‰\r˜£”‚¦\f\r“\f\f\f¥¤Ø¢‡¥\f£§Ø¥¢‡·””šµ¤‡¤¤¥œ„…Ÿ°Ê \t¾»\f¼—\r\r¢¢\r–\f“–\f\fžŸ\f‡ž«™\f„•—\r\r¬˜ž\f«™\f„\b\fŒ\f””\f´©©\f”™”™˜\r\f\r–\f—‹“‹\f\f˜\r\f´™\r“\f\f\f\rž„„‹³‚´„ƒ‚€¬†ƒ†€¸ƒƒƒ·º·ƒ„‚€²\n„ƒ  €\n²Ì‡ƒ†ƒºƒ‚€²€ºƒ·‡´»µ€‚ƒ¹„ ƒ‚¬º€¶‚„ƒ³ ¹€ƒ‚€¶¬„‡ƒ‚€†ƒ‚‡ƒ·º†ƒƒ ƒ»†ƒ‡‡¼ —«Š\f\r—‹…\r\n\rŠ\r\r\f\f‚ ‚\f\f¹\f\fá…\f\f\f\f\f\f\f©¥¡ã꩹¨§ä£¥Éœœ¯ž¹ëë¿®›®°Èë¡¥¨©£¡£ë¥ã§¢ã§¦ã©¥¡ã©¨§£¥Œ‚ˆ€‚\f±\b¼À½½¿¼¼¿º¼\b¼¼½\b¼¼¼\b\b½\b¼\bºº¼¼º¼¿¿\b½\b„ ¹\b\t\b½\b\b¹\t¼ÃÅ\b¿\b¼\b½\b½\b¼„€‚‚ƒ„\fÁ½À\t¹º¥¢¤\b¼š¿\b\b»·¡„¡Ø§„¢£\b¼œ\b½\b½\b¼„±½¿\b»\tšÐ·¤œÃÅ\b¿À\b¼»¹¶º\b¼\bº£ÀƼ\b¼\t»Ï\b¹\b\b\b»¼À\b¼\t¼º½Â\t¼„±»\tšÐ·¤œ½\b¼À\b\b\b»¼Â\t¼\b\b„Á\b¿¼\t¼À\b¼¼¼¼º¾¥¤¤¿¿¹¼\t\b\b\b»¼\bšË œ\bº°Ê \t¾»é¼„…†\f¹º\b¼¾½¼\t»½\b¼¹½¿\b\bº»\t¼À\b¼¿\b\b¾Ò¨§Ø¢„£\bº¨¡Ø¢„¥‡¼¹„±¢º\b¼\b\b½\bÀ\b¼¿\tº½¿\b«·¬Ø¢„¥¿¿¹¼\t¼¨¢Ø£„¡¿¿½»\tšµ¤„¤§œ„±£¿½¼½¼º¼¿\bº\t¥¤Ø¢„¥\bº£§Ø¥¢„·¿¿šµ¤„¤¤¥œ‡¼¹„±½¿\b»\t½¼\tÀ\b¼\b¼¼¼¼º\b¼½Å\bº»º¢¢\b¼‡½¼\b¼\b¼¼\b¼\b¾ºÊ \t¾»é¼„±½»\t½»º¼\tÀ\b¼ºº¬‡¼\b¼\b«¡\b¼¼„‡‚ˆ†€‚\fÝÅ\b¿¿\b¾¼ºº\b¼\b¹\b¹\b\b»¼\b»Ñ¼\b½\b¼„½£ž¾‘ŒŸ¥¬¢£ŒŽ‘¢£Œ–›Ž’£–•£¥›¡£¥Ž–²Ï£—‘ÂŽ¤–š²–Œ›¡Œ‘¢—–¥›ž²¡Ž¢Ê‘Ž•›À‘•˜—Ž¤›‘˜Ž•›£Œ£¥›¬›¡£–”›¡‘Œ¥¥›–›£•‘¤‘•˜—Ž¤›‘˜Ž•›£Œ£¥›Á”•ŸŽ•œ¬›¡£¥›”Ÿž¾–¥¢£Œ˜‘Œš£Ÿ¾Ž›¡•‘£Â›£Œ•–—˜”•ŸŽ•œ¶™¨Ç¥Å²Å¥™š‹º®ž±œ™¥š©—³®˜œ™š¥¨”–™——™¼“¥”™®•£®•°¥Îµ°›®¯µ°™œ›¬µÅšµžœÉµž›™¹œ®¿®®°š®œœ®¿®áÏÏΰ›®°®¬Æ®—°š™²®Ãа™—˜™œ®²®È™š¿Ä°œÉ®¯µ¿›´ž©¥¡ã꩹¨§ä£¥”›š»—žž›™š•Éœœ¯ž¹ëë¿®›®°Èë¡¥¨©£¡£ë¥ã§¢ã§¦ã©¥¡ã©¨§£¥¢§\b£\n¢§\b£®§§¤¦§¤£¹\n¨\n\n\b\n\n¨\nº„ „⼝¹†‡ „„³¹‡¯„„Ã\b¹¹‡Ë„„\b¹Æ»™›²³™Â½²›š›´™²–®ž¯›œ™²Ø™°®ž²™¬²ÓêÏ®°œÉµ°š¼œ™œµÍµ¿›´™²Ñš›¬µ°ž›œÂÅ°¶É™šÈµ²Óž¶ê–®ž¯›œ™²™œ¾ž™¶®È®°¶™¼œ™œ›®šÅ°¶É™šÈµ²Óž¶»—žž›™ CC BY 4.0©¨«\f\n\n\r\nŽà\f€\f‚ \f\f\f\f ‰\f\f\f\f߀ ‚\f‰ \f‰‰\f«¥äã¥ðì¡ä¨í‡ ‡‚\f\fâ\f‚ \fˆ‡‚\fß\f€ˆ\r\r\f߀\f€\f \f\f\f \f\fˆ ‰\f‰’\fˆ ‰\r€‰”‰ \f \f\f\f ‚\f•…\f\f\f€ €\f‰\f\f€\f\f\f\f‰ ‚\f‰‰\f €\f\f ©¥¨¥¸\f‰¡¢§ð ‚‰«¥ðì£íâ \f\f‰€ \f‚\f€ß\f\r\f‡ˆ’\f€ˆ\f \f‚‰\f‚ì£«í„ €‡‰\f\f€€\f‚’’\fˆ‡‚\f‚\f‚‡‰\f€\f‰‡\f\f€\f\f»Ù®—°šµ\fì«í\f ¡¦¥¨‚‰ß\f‰¸ \f\f¡¢ð\f\f\f ˆ\f\f‚\f\f\f\f‚‡\fÔÚ²¿µ\f\f §§©‚‰\f‰‡ € ¨ä£ˆ€”©«ð•\f‡‚¡«ð\f\f\f‰‚ì§íŽ€ˆ\f \f\f‰\f€ß‰\f\f€ß‚ €‰\f\f\f…‚\f\f\r\f€‚‚\f\b  ‚è\f\f\f߀\f\f€\f\fß\f\f \f\f\f€\f\fˆ\f\f\f\f¸\f\f€\f‚è‡ \f\f‚\f\f ˆ\f€‚\f\f‰‰¹ˆ\f\r\f‡’\f€\f€ \f\f‰\f€ß€ ‚\f‡‰\f \f‰\f\f\f‡€\f‡\f\f\f\f‰\f\f€ ß\f‡\f’‡‰\f€‡\r\f¸‚\f\f\f€\r‰\f\f\f\f‰\f€\fì¦íŽ\f‡€€\f€\f‚ˆ\fß\f\f‚ \f‰’\f‚‰\f \f‰\f€\f\fˆ‡’\f\f\f\f\f\f\f\f\f€\f\f\f\fà\f€\f\f\f€\f \f\r\f‡‚‚\f\f\f\f\r\f\f\f\fß\f‚\f\f\f\f\f‰\f€‡’\f‰\f\f\f‚\f€\f\f \fˆ\f‡‚€\f\f\f€\f‡\f€‚‰\f\f \f€\f\f\f€ß\f\f‡’\f\f\f߀\f‚‡\f\f\f\f \f‚\f‰\f€\fß\f‚‡\f\f‡\f\r\f‡\f\r\f€\f\f\f \f‚‡¸\f\f\r\f \f‚‰\f \f\f‚\f\f\fìã¢íˆ¸‰\f Žˆ\f‡¸\f\f€\f‡‚ \f\f\f\f\f¸ \f\f‰\f\f‡€\f\f‚ ‚\f\f\f’\f\fì¢íŸ\f\f¹\f €\f¸\r\r\f\f\f\f\f\f\fß\f‰¸ \f\f ‚‚‡\f‰\f\f¡©¥\f‰\f¸ \f\f ‚\f \f‰ˆ€\f\f§£ˆ’\f «¨¦©”\f §£§ï«©¨•…\f‚\f‚‚\f\f€\f”\f€\f\f€•\f€\f\f \fŒ†\fŠ \f\f¸ \f\f‡‚\f\f\f\f€\f\f\f\f€\f ‚\f ‚”ß\f‚\f•ˆ\f‰\f‚\f\f‰\f\f€\f \f‚\f\f ‚\f”\f\f•\f\fˆ\f\b\r\f§¥\fˆ„\f\f€\f\f\f”\f÷• ¡«ˆ¨¥ €\f€¹ ‡\f\f\f\f\fè\f\fˆ\f\f€\f\f‡’\f…\f\f¨‚\f‡\f \f\f€\f\f”•…\f\f‚ ‚\f\f‚\f‡\f\f\t‚\f\f\f€\f ‚\f\fˆ\fß\f\f\f€\f¸ \f\fâ\r\r\f€\f\f\f\f\f‚\f¡¥¥\f\f\f ß”…·•\f\f€\f‚è\f‰‚\fßÁÓŗʛȚµ\fήžœµ²ì¡¥í\f‡’‚\f‚è\fˆ\f\f‚‰\f\f\f \f\f\f‰‹ß\f¡¦ä¡ã‚ €\f\f€¡«ä¡§‰ß\f¡¨ä¡£\f¡©\f‚\f\f\f ‚\f –\f\f‹‡ \f€\f€\f\f\f\f€\f €\f\f\f³ò¥¥«‚\f\r\f‰¨ä£†‰ˆ‚\f\f‚\f‰‚\f”‚\f•ˆ\f\f\f\f€\f €\f\f€\f‰‚\f…·Š§¢”§«¦¨•ã©”¦ãããò¥¥¥«ê‚\f•©\f\f\f\f\f\f\f‚’\f \f€¨\f\f\fˆ \f\f€\f\f\f €\f€\f£ä«…‚\f€\f‰\f‰\f\f‚߁¨«ð\f\f\fß‚\f‚ˆ¸\r\r\f\f\f €\f\f„‚ˆ‚€\f\f€\f\f\r\f\f\f\r\f \f€\f\f\f¦€¨ä£ß€ê¸‡€ˆ\f\r\f\fˆ\f ‰\f\f\fŽ\f€\fß\fˆ\f‚\f\f\f€\f‚è\fˆ\f\f\f‰‰\f\f‚\fˆâ‡€‚ˆ\f‰\r\f \f€\f\f \f‰‘\nŽ‰\f\r\f \f\f€\f\f\f‚\f‚ ˆ\f \f€¸‚ ˆ\f\f„‚’\f\f‚‰ß‰\f‚€‰\fˆ€\f߀€\f\f\f€\f\fß\f\f\f‚‡Ž‚\f€ ¨¸ \f\f ‚ €ß\f\r\f \f€\f\fŠ©©€\f ’\f\r\f \f€‡\f\f‚\f\f”\fˆ‰\f\f‚ß\fß\f\f\f•\f‚\f€ \fßÁÓŗʛȚµ\fήžœµ²ì¡¥í¸\f\f \f\f€\f‰ß\f ¡§¡ã‚¨ã€ ¡¨ä¡«‚\f‰ˆ\f‚‡’\f‰\f \f‰\f\f€\f\f‚…£\f ßÁÓŗʛȚµ\fήžœµ²‚\f\f \f\f”¡©‚•†\f‚\f‰\f\f€¡\f‚€\f \f\f\r\f\f”\f\f\f‰‚\r‚\f‹„âˆ\f‹\f‚\f•‰\f‰\f\f€\f\f\f \f‚\f\f¸ ”\f\f\f\f\f•€\fˆ€\f£¨\f€\f\r\f\f‚\f\f”¾¾¾ä¾Ô\f\r\f\f\fÙ°®®¶µ°•\f €\fß\f\f‚è\fˆ\f\fˆ‚\f…¢€‰\f\f‰ß\f £¦\f£\f€‚яß\f‡\f\f \f‚ˆ‰¸\f\f\f\f\f€\f\f€\f‰\f‰ ‚\f\f‰\f€\f\f‚\f\f¸€ˆ\r\f\f¢†¥‡ˆ‰£\n\r\b\r›\r\t— €„\f \t\f‚ ˜‘\f\n\r ƒ„\t\b \f‚\t …„\b\tŒ¦\f\f‹\f\f©©¨„ã«ï©¨”ã¥ä¢¥•§¢ï©¡ó”§«ä¦¨•¨§ï©§ó”¨¨ä£©•¡¥ï©¡óó”§ä¡£•Žã£ï©¡”¦¢ä¢¡•ã©ï¨£”¦ãäãã•«§ï¨§”«¥ä§¡•¨«ï¡©§”¡¥ä㥕\f€\f…‚‰ ¢«ð\f\f‹\f\f€ €\f \f€\fˆ\f¹ó³ò¥¥«êóó³ò¥¥¥¡¨¯‰\f€‚\fß\f\f €¸\f‰‚‰\f \f\f\f”…•\f ‚\f\f\f‚\f‡\f\f ©€‡’‡ \f \f€\f\f\f\f ¡€ \f \f\f \f‚€ˆ\f\fˆ‚©¥ß\f\f\f\f\f ‰\f\f\f\f‰‹æŽì¡¡í\fß\f‰©¢\f\f‰\f\f€\f‰\f\f€\f\f‰\f‚‰\f\f‰ß\f\f€\f\f\f‚ ˆ€\f߀\f€\f\fŒ€\f€ß\f\r\f€‚€‚‰ì¡©íæ‹Ÿ\fì¡¨í\f\f \f\f\f\f \f‡\f\f €ˆ \f‚\f\r\f\fŒ†Š\f\f\fâ¸\r\r‡\f ‰\f \f¹\fˆ\f\f \f\fß\f\f‡’\f\f\f\f¹\f\f\f\f\f\f\fê‰\f¸\r\r¹ˆ\f\f ‰\r\f\f\f\f \f \f‰’ˆ\f ‰\fì¡£í\f\f\f‚\r\f\f\f‚\f‡\f ‰\f‰’ì¡«í\f\f‚‚ ¸\r\r\f\f\f\f ‰‹\f…ˆ\fß\f‰\f€\f¨ã«¥§‚’\f”©¥¥©ä©¥¥§• ‰ˆ\f‰ ‰\f‰\f¸ \f\f €ß\f‰ ”\f•ì¡«íß\f‚‡\fˆ‡‚ \f‡¸\r\r\f\f€\f€‚‰\f\f\f\f\f\f\f‚\f\f\f ©€\f\f‚‚\f\f‚\f‚‰\f‡ \f\f‰‰’\f\r\f\f¸\f‰\f\f€ˆ‚€\f€ß\f ¸ \f\f‰\f\f\r\f\f\f¸ ‡\n\r\nŽ\f\f\f‡¸\r\r\f\f\f\f”\f÷•\f\f\f\f\f\f ¦\f\f\f€\f¨\f\f\fß\f‰¸ \f\f ‚† \f\f \f\fˆ\f’\fˆˆ‚\f\f\f\f\f‚\f\f\f\f\f€‡€‚€\f\f‚€\r\f \f€\f\f‚\f\f\f\f\fß\f€\f \f\f\f€ˆ\f \fÃÄÅÁÅÅ\bÀÅÆÇ¡Ž\f €\f\f‰\f\f‰\f\f ‹\f©¥¡§ê¡¥”¡•¹§¦¦¡ì¾”·œ£®•°°Ðɵ¯²™´µ™š¿¬™²—µ®Ãš®šžœµ°®›¿™²™šœ››šÃ²™˜˜™œ®°Â¿°—Èž›šœÉµœÉµ°™¯Â®Ã®žœµ®™°œÉ°›œ›žÍ®¿µ°š»Éµ—˜™œ®²®ÈÂÆ®—°š™²©¥¡§ê¡¥”¡•¹§¦¦¡”›š»—žž›™š•í¿®›¹¡¥¡££¡©ë¡¢¢§¦¥¡©©¥¡§¡§¦¦¡©ŽŽ\tËâ \f\f ‚\f¹¸\f\f\f€\f\f\f\f€ˆ\f \fâ\f€©¥¡¨ê㹫©¦ì¾œž®±œ™¤¾ª®žœ™¨Ç¢×š¿®¯°®œÉµž›ž°µ¯²™´µ˜µšœ®ÃÉ›¯™š¿¶šµµÞ®›šœž¹µ¯›¿µ˜›®²®È›´™²™ž¯µ´œž™š¿µÃõ´œ®šÛ—™²›œÂ®Ã²›Ãµ–—˜™šµ´®²®ÈÂÆ®—°š™²©¥¡¨ê㹫©¦”›š»—žž›™š•í¨’†Š‡ƒ\t‹\f‰\f \f¸ \f\f ‚Š\f\f\f\f\f©¥¡£ê”©•¹«¡¨ìÀ®£§®˜œ™¼¨¥§¢Ÿ•¡”£œ™¯¯ªœ™”˜—•£œš²—–”˜Ðɵžœ°—´œ—°µ®Ãµ™°²Â°µ¬›ž›®šž™Ãœµ°É›¯°µ¯²™´µ˜µšœÐ°™—˜™œ®²®È™š¿®°œÉ®¯µ¿›´ž®Ã»—žž›™©¥¡£ê”©•¹«¡¨”›š»—žž›™š•íÉœœ¯ž¹ëë¿®›®°Èë¡¥©¡ã©¨ë©¨¡¡©¢¥«©¥¡£¥©«¡¨£´––—•¼™”•¼œ—ž¬¢•·“¨“®½”™—–»¥Ð°µš¿ž›šœÉµš—˜Êµ°®Ã¶šµµ™š¿É›¯™°œÉ°®¯²™žœ›µž¹´®šž›¿µ°™Ê²Â˜®°µ¶šµµ™š¿É›¯¯°®žœÉµžµž¿—µœ®®žœµ®™°œÉ°›œ›ž›š©¥¨¥Ïµ¿Ð›Þ¿ž´É°Çµšµµž¶¿©¥¡¥ê¡«£¹Å¡«¨£ì›šÁ—œ´Éí«¾œ¢ž•—¼¸§—±Äœž–§¾¤”™®±š—–”˜Î™œ›µšœž™œ›žÃ™´œ›®š™Ãœµ°œ®œ™²¶šµµ™°œÉ°®¯²™žœÂ¹³É®›žž™œ›žÃ›µ¿™š¿³É®›žš®œá½²›šÄ°œÉ®¯»µ²™œ»µž©¥¡¥ê£§ã”¡•¹«¦§¨¿®›¹¡¥¡¥¥¦ëž¡¡¢¢¢¥¥¢¡¡¡¢¢§Ã¡˜·—°»—Ę—––¥©—”ž¬œ•–§¯¤®—³³—“ε°ž›žœµšœ¯™›š™Ãœµ°Þ®›šœ°µ¯²™´µ˜µšœ¹¯°µ¬™²µš´µžµšž®°ÂÛ—™²›œ›µž™š¿¯®žœ®¯µ°™œ›¬µ¿µœµ°˜›š™šœžÎ™›š©¥¡¡ê¡«©”¨•¹«§§¦©¿®›¹¡¥¡¥¡§ëÞ¯™›š©¥¡¥¡¡¥©¨\r\f\n\t\b\n\t\f\n\f\t\f\f\t\n\f\tŽå ‰ˆ\f ‰\f…”¡\f‰ •ì¡«í¶¥¸ŽÒ°µÛ—µš´Â®Ãžµ°›®—ž´®˜¯²›´™œ›®šž™žž®´›™œµ¿³›œÉœ™¶›šÈϼžÁž”¯µ°¡˜›²²›®š¿®žµžœ™¶µš•ì¡«íª¦…\rŽ‚‡†à\f€\f‚\f\f\f\f‚\f\f\f\f€\f\fŽ\f\f \f\f©¥¡¦ê¡¹£¨¦ìº®ž±œ™¥š¾—˜œ™›°¸§¢§žœ™”¨›½É°®š›´¯™›šžÂš¿°®˜µ›šœÉµ²®šÈœµ°˜¯®žœ®¯µ°™œ›¬µ¯µ°›®¿™š¿œÉµ¯°®Ê²µ˜®Ã°µ¯™°™œ›¬µ°µÈµšµ°™œ›®š›š´™žµ®Ã´®˜Ê›šµ¿œ°™—˜™Íµ¿›´›š™Ö›°È›Õ››©¥¡¦ê¡¹£¨¦”›š»—žž›™š•í㸘”¢Ä¤ÅÁ›™Èš®ž›šÈ™š¿œ°µ™œ›šÈ´É°®š›´˜—ž´—²®ž¶µ²µœ™²¯™›šÊ™žµ¿®šœÉµ—š¿µ°²Â›šÈ˜µ´É™š›ž˜”ž•ÙµžœÎ°™´œ»µž½²›š»Éµ—˜™œ®²©¥¡«ê©¢”¡•¹§¡¢¿®›¹¡¥¡¥¡§ëÞʵ°É©¥¡«¥£¥©£¢ŽŽ\f\f‚ ‚\f\f\f‚‡’\f‰\f\f\f¸ \f\f\f‰¹\r\fö‹‚ê©¥¡£ì¾œž®±œ™¤¾Îµ°›®¯µ°™œ›¬µ™šµžœÉµž›™™š¿Ê²®®¿ž™¬›šÈœµ´Éš®²®È›µž›š²™°ÈµÞ®›šœž™°œÉ°®¯²™žœÂÁ°˜µ¿ž´›Á›žž¼œÎµœµ°žÊ—°Èê©¥¡£”›š»—žž›™š•í¡¥¤«š¢Ÿ®¶•é¼¨“œ±–—˜¨Ðɵ´²™žž›´¹Ã—š´œ›®š™²°µž—²œž®ÃÉ›¯™°œÉ°®¯²™žœÂ³›œÉ™´°Â²›´¯°®žœÉµž›ž¡¢«£½²›šÄ°œÉ®¯»µ²™œ»µž©¥¥¢ê£§¦”¡•¹¦©¦¿®›¹¡¥¡¥¥¦ëž¡¡¢¢¢¥¥ã¥«¦©¡¡¡\t„„\n\f\f\f¹Š\f€\f‰\f©¥¡§ê¡©¹¡«¢§ã쪔ž”–——™š¹²”±œ•œ™¹©Íµ²®À›´™˜›š»—žž›™¹Âµ™°žœ®ÈµœÉµ°Ðɵ°™¯µ—œ›´™°É›¬µ©¥¡§ê¡©¹¡£¢«ã”›š»—žž›™š•í¿®›¹¡¥¡¦¡¡§ëœµ°™°¶É©¥¡§ãã¡©¡£¢¡«ã¡© €†ƒ\r\f\f\f\f\f\f\n©¥¥ãꡧ¹«£¦ìµ”¶œžœ·•®®²°µ”§”ž¡”•²›“”•–—˜——™”š¥—–”˜Ðɵ™¯¯²›´™œ›®š®Ã˜®¬™²›ž›š®¯µ°™œ›¬µ®°œÉ®¯µ¿›´žÎÉ™°˜™œµ´™©¥¥ãꡧ¹«£¦”›š»—žž›™š•í¡¨Ð„\rŽ‡ËÑ„\n¸\f€\f\f \f\f\f‚‰ \f\f\fŽ€\f\f€\f©¥¡«ê¡¹§§¦§ìÀ±™—–£œ™”¹¥¾—˜œ¢±œ™¤¿šÆ”•”±¡—™”ÎÉ™°˜™´®µ´®š®˜›´™š™²Âž›ž®ÃÍ®¬™²›ž›š¯™œ›µšœž³›œÉ®žœµ®™°œÉ°›œ›ž™š¿°Éµ—˜™œ®›¿™°œÉ°›œ›žÇ®®¿´²›š›´™²¯°™´œ›´µ©¥¡«ê¡ê§§¦§”›š»—žž›™š•í¡£¨”±–Ÿ—ž¶—•¥¸¾®®Ì˜±¬”Åé”Æ—Ÿ—žº“¼µ²µ´œ›¬µ½Äç©›šÉ›Ê›œ›®š›žÃ™¬®°™Ê²µœ®É—˜™šµ™°²Â™š¿²™œµžœ™Èµ®žœµ®™°œÉ°›œ›ž´™°œ›²™Èµ¹™É—˜™š›š¬›œ°®žœ—¿ÂÄžœµ®™°œÉ°›œ›ž½™°œ›²™Èµ©¥¥«ê¡¨”§•¹«¡¢©§¿®›¹¡¥¡¥¡§ëÞÞ®´™©¥¥«¥©¥¥£¡«©”³—¡ž—¨—±–ž—¨›žœ˜˜—”¢¥¨œ•–”±–ž¢½ÅÅ¿¬µ°žµ¿°—È°µ™´œ›®šž™žž®´›™œµ¿³›œÉœÉµ—žµ®ÃϼžÁž¹´™žµëš®š´™žµ™š™²Âž›ž®Ãž¯®šœ™šµ®—ž°µ¯®°œžÃ°®˜œÉµÒ°µš´É¯É™°˜™´®¬›È›²™š´µ¿™œ™Ê™žµ©¥¥©©¥¥§Ò—š¿™˜½²›šÎÉ™°˜™´®²©¥¡¨ê©¦”©•¹©©¨¨¥¿®›¹¡¥¡¡¡¡ëÞ¡£¦©ã©¥§©¥¡¡¥¥¢¢¡À\f\n\n\r—‘\fŠ‹…\rŸ\f\f\f\f\fƒŽ\b“ê\n\r€ˆŸêŠ \r\f\f\f\f\f‰\f\f\f‹\tê\r\r—\rŠŠ\f‹\n\f‹\f€×˜™›²¹žµ°È¨¦«±Â™š¿µÀ°—µ™šÅ²ÇÅ‹Ò›°ž®¬¼µ°ÈµÂÅÁ°˜µ¿ž´›–µ™¿®Ãа™—˜™œ®²®È™š¿Ä°œÉ®¯™µ¿›´ž½µšœµ°»™›²³™Â½²›š›´™²–®ž¯›œ™²Ø™°®ž²™¬²Óט™›²¹žµ°È¨¦«±Â™š¿µÀ°—×
About the authors
S. A. Firsov
Railway Clinical Hospital
Email: serg375@yandex.ru
A. S. Lepilov
Railway Clinical Hospital
R. P. Matveev
Northern State Medical University
V. S. Savinkin
Hospital at Isakogorka Station
References
- Бадокин В.В. Место и значение нестероидных противовоспалительных препаратов в терапии остеоартроза. Современная ревматология. 2016; 10 (1): 67-71. doi: 10.14412/1996-7012-2016-1-67-71.
- Борисов Д.Б., Киров М.Ю. Эндопротезирование тазобедренного и коленного суставов: эпидемиологические аспекты и влияние на качество жизни. Экология человека. 2013; 8: 52-7.
- Тихилов Р.М., Шубняков И.И., Коваленко А.Н. и др. Структура ранних ревизий эндопротезирования тазобедренного сустава. Травматология и ортопедия России. 2014; (2): 5-13. https://doi. org/10.21823/2311-2905-2014-0-2-5-13.
- Otten R., van Roermund P.M., Picavet H.S. Trends in the number of knee and hip arthroplasties: considerably more knee and hip prostheses due to osteoarthritis in 2030. Ned. Tijdschr. Geneeskd. 2010; 154: A1534.
- Bourne R., Chesworth B., Davis A. et al. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin. Orthop. Relat. Res. 2010; 468 (1): 57-63. doi: 10.1007/s11999-009-1119-9.
- Wylde V., Hewlett S., Learmonth I., Dieppe P. Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain. 2011; 152 (3): 566-72.doi: 10.1016/j.pain.2010.11.023.
- Фирсов С.А., Белов Г.В., Чухрова М.Г. Хронический болевой синдром в отдаленном послеоперационном периоде и проблема репаративной регенерации при сочетанной травме. Медицина Киргизии. 2017; 1: 43-7.
- Clauw D.J. Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s). Best Pract. Res. Clin. Rheumatol. 2015; 29 (1): 6-19. doi: 10.1016/j.berh.2015.04.024.
- Борисов Д.Б. Периоперационное обезболивание и кровесберегающие технологии при эндопротезировании крупных суставов: Автореф. дис. ... д-ра мед. наук. СПб; 2014.
- D’Aubigné R.M., Postel M. The classic: functional results of hip arthroplasty with acrylic prosthesis. 1954. Clin. Orthop. Relat. Res. 2009; 467 (1): 7-27. doi: 10.1007/ s11999-008-0572-1.
- Каратеев А.Е., Насонов Е.Л. Мелоксикам в России: 20 лет вместе. Терапевтический архив. 2016; 12: 159-68. doi: 10.17116/terarkh20168812149-158.
- Загородний Н.В., Захарян Н.Г., Пантелеева А.С. и др. Применение Мовалиса в оперативной ортопедии. Фарматека. 2008; 16: 54-7.
- Цветкова Е.С., Белоусов Д.Ю., Афанасьева Е.В. Фармакоэкономический анализ применения препарата Мовалис у больных остеоартрозом и ревматоидным артритом. Качественная клиническая практика. 2015; 1: 66-76.
- Mastbergen S.C., Biijlsma J.W., Lafeber F.P. Selective COX-2 inhibition is favorable to human early and latestage osteoarthritis cartilage: a human in vitro study. Osteoarthritis Cartilage. 2005; 13 (6): 519-26. doi: 10.1016/j. joca.2005.02.004.
- Lapeyre-Mestre M., Grolleau S., Montastruc J. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006. Fundam. Clin. Pharmacol. 2013; 27 (2): 223-30. doi: 10.1111/j.14728206.2011.00991.x.